- Home
- REAL vs GHRS Comparison
REAL vs GHRS Comparison
Compare REAL & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- GHRS
- Stock Information
- Founded
- REAL 2011
- GHRS 2018
- Country
- REAL United States
- GHRS Ireland
- Employees
- REAL N/A
- GHRS N/A
- Industry
- REAL Other Specialty Stores
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- GHRS Health Care
- Exchange
- REAL Nasdaq
- GHRS Nasdaq
- Market Cap
- REAL 641.9M
- GHRS 737.5M
- IPO Year
- REAL 2019
- GHRS 2021
- Fundamental
- Price
- REAL $5.31
- GHRS $14.76
- Analyst Decision
- REAL Buy
- GHRS Strong Buy
- Analyst Count
- REAL 5
- GHRS 8
- Target Price
- REAL $8.40
- GHRS $30.63
- AVG Volume (30 Days)
- REAL 3.0M
- GHRS 204.8K
- Earning Date
- REAL 08-05-2025
- GHRS 05-08-2025
- Dividend Yield
- REAL N/A
- GHRS N/A
- EPS Growth
- REAL N/A
- GHRS N/A
- EPS
- REAL N/A
- GHRS N/A
- Revenue
- REAL $616,717,000.00
- GHRS N/A
- Revenue This Year
- REAL $11.70
- GHRS N/A
- Revenue Next Year
- REAL $10.10
- GHRS N/A
- P/E Ratio
- REAL N/A
- GHRS N/A
- Revenue Growth
- REAL 11.89
- GHRS N/A
- 52 Week Low
- REAL $2.24
- GHRS $6.00
- 52 Week High
- REAL $11.38
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- REAL 52.98
- GHRS 66.16
- Support Level
- REAL $4.71
- GHRS $11.82
- Resistance Level
- REAL $5.30
- GHRS $12.94
- Average True Range (ATR)
- REAL 0.26
- GHRS 0.99
- MACD
- REAL 0.04
- GHRS 0.19
- Stochastic Oscillator
- REAL 100.00
- GHRS 84.53
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.